Narcisa Mesaros
5 Embassy Links, Cunningham Road
Bengaluru, KA 560052, India
Bengaluru, KA 560052, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Considerations for assessing the feasibility of network meta-analysis of seasonal vaccines.
Journal: Journal of comparative effectiveness research
Published: June 29, 2026
Enhancing vaccine clinical trials participation among elderly: challenges and strategies.
Journal: Trials
Published: October 28, 2024
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies.
Journal: Infectious diseases and therapy
Published: July 22, 2022
Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized, observer-blind clinical trial.
Journal: Respiratory investigation
Published: June 21, 2022
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
Journal: The Journal of infectious diseases
Published: May 27, 2022
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.
Journal: Vaccine
Published: November 19, 2021
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
Journal: Vaccine
Published: September 09, 2020
Corrigendum to 'Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults'. [Vaccine 36 (2018) 6325-6333].
Journal: Vaccine
Published: February 17, 2020
Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study.
Journal: Human vaccines & immunotherapeutics
Published: June 20, 2019
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
Journal: Human vaccines & immunotherapeutics
Published: November 17, 2018
Last Updated: 09/26/2026